S&P 500 Financials Sector SEC Filings — January 08, 2026

09-01-2026

Welsbach Technology Metals Acquisition Corp. filed an 8-K on 2026-01-09 (AccNo: 0001213900-26-002600, Size: 5 MB) disclosing entry into a material definitive agreement (Item 1.01), completion of acquisition or disposition of assets (Item 2.01), creation of financial obligations (Item 2.03), unregistered equity sales (Item 3.02), modifications to security holder rights (Item 3.03), changes in control (Item 5.01), director/officer changes (Item 5.02), governance amendments (Item 5.03), and code of ethics amendments (Item 5.05). This indicates a significant merger/acquisition event likely involving a SPAC de-SPAC transaction, but target identity, deal terms, valuation, and financial details are NOT_DISCLOSED. Sector is not specified.

09-01-2026

City Office REIT, Inc. filed an 8-K on January 9, 2026 (AccNo: 0001193125-26-009080, Size: 221 KB), disclosing termination of a material definitive agreement (Item 1.02), completion of acquisition or disposition of assets (Item 2.01), notice of delisting or failure to satisfy listing standards (Item 3.01), material modifications to rights of security holders (Item 3.03), changes in control of registrant (Item 5.01), departures/elections of directors/officers (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific parties, deal structure, valuation, or financial metrics are disclosed in the provided summary. This indicates a major corporate event likely involving a merger/acquisition completion leading to change in control and delisting.

09-01-2026

Buda Juice LLC filed a Form 8-K on January 9, 2026 (AccNo: 0001493152-26-001094, Size: 1 MB), reporting multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item material event filing from the US SEC with sector not specified. No specific transaction details, dollar values, named entities beyond the filer, financial metrics, or other quantitative data are disclosed in the provided information.

09-01-2026

Ellington Financial Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001628280-26-001437, Size: 215 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the core event, transaction, financial impacts, or quantitative metrics are disclosed in the provided filing summary. All numerical values, named entities beyond the filer, and event specifics are NOT_DISCLOSED.

09-01-2026

TrueBlue, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001140361-26-000754, size 198 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No details on the specific other event, transaction, financial statements, or exhibits are provided. Sector is not specified.

09-01-2026

Alumis Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001104659-26-002265, Size: 471 KB), reporting under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a financial results disclosure from the US market, but no specific financial metrics, transaction details, or quantitative data are mentioned in the provided filing summary. Sector is not specified.

09-01-2026

MacKenzie Realty Capital, Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001550913-26-000002, Size: 180 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial statements, or exhibits are provided in the filing summary. Sector is not specified.

09-01-2026

SUI Group Holdings Ltd. filed a Form 8-K on January 09, 2026 (AccNo: 0001654954-26-000203, Size: 170 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the affected officer, position, appointment/resignation, reasons, or quantitative data provided in the filing summary. Sector not specified.

09-01-2026

Arrowhead Pharmaceuticals, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-007971, Size: 1 MB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, events, transaction values, or financial impacts provided in the available information.

09-01-2026

News Corp filed a Form 8-K on January 9, 2026 (AccNo: 0001564708-26-000006, size 400 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other event, financial statements, exhibits, transaction values, or impacts are disclosed in the provided filing summary. Sector not specified.

09-01-2026

Soren Acquisition Corp. filed an 8-K on 2026-01-09 (AccNo: 0001213900-26-002637, Size: 1 MB) disclosing a merger/acquisition event with Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), and Item 9.01 (Financial Statements and Exhibits). No specific details on deal structure, parties involved, valuation, transaction value, share counts, percentages, financial metrics, or strategic rationale are disclosed. Sector is not specified.

09-01-2026

Sound Point Meridian Capital, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001829126-26-000121, Size: 254 KB) reporting under Item 8.01 Other Events. No specific details on the event, transaction, financial impact, or other quantitative data are disclosed in the provided filing summary. Sector is not specified.

09-01-2026

Silicon Valley Acquisition Corp. filed an 8-K on January 9, 2026 (AccNo: 0001213900-26-002599, Size: 331 KB), disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), other events (Item 8.01), and financial statements and exhibits (Item 9.01). This filing relates to a Merger/Acquisition event in the US market, but no specific parties, deal structure, valuation, or quantitative details are disclosed. Sector is not specified.

09-01-2026

IX Acquisition Corp. filed an 8-K on 2026-01-09 (AccNo: 0001104659-26-002235, Size: 255 KB) disclosing under Item 1.01 entry into a Material Definitive Agreement related to a merger/acquisition, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on parties involved, deal structure, valuation, consideration type, strategic rationale, or financial metrics are disclosed in the provided filing summary. Sector is not specified.

09-01-2026

Lionsgate Studios Corp. filed a Form 8-K on January 9, 2026 (AccNo: 0002052959-26-000004, Size: 170 KB), reporting under Item 8.01 Other Events. No details on the specific event, transaction, financial impacts, or named entities are disclosed in the provided filing summary. Sector is not specified.

09-01-2026

FormFactor Inc filed an 8-K on January 9, 2026 (AccNo: 0001039399-26-000002, Size: 145 KB), disclosing under Item 2.05 Costs Associated with Exit or Disposal Activities and Item 2.06 Material Impairments. No specific dollar values, transaction details, strategic context, financial impacts, or other quantitative data are provided in the filing summary. This appears to be a multi-item mandatory disclosure signaling potential restructuring and asset write-downs.

09-01-2026

Haemonetics Corp filed a Form 8-K on January 09, 2026 (AccNo: 0000313143-26-000003, Size: 723 KB) reporting Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financials, or exhibits are disclosed in the provided filing summary. This is a multi-item filing from the US SEC with sector not specified.

09-01-2026

RYVYL Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001185185-26-000081, Size: 26 MB), reporting unregistered sales of equity securities under Item 3.02 and financial statements and exhibits under Item 9.01. No details on transaction value, share count, or financial impacts are disclosed. This is a multi-item mandatory filing focused on equity securities compliance.

09-01-2026

Carter's Inc (CARTERS INC) filed a Form 8-K on January 09, 2026 (AccNo: 0001060822-26-000002, Size: 255 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results disclosure with no specific revenue, earnings, or other numerical metrics detailed in the provided filing summary. Sector is not specified.

09-01-2026

Liquidia Corp filed a Form 8-K on January 9, 2026 (AccNo: 0001104659-26-002306, Size: 229 KB), disclosing Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the content of the Regulation FD disclosure or the nature of the financial statements/exhibits are provided. Sector not specified.

09-01-2026

Brookfield Asset Management Ltd. filed a Form 8-K on January 09, 2026 (AccNo: 0001171843-26-000153, Size: 224 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific event, transaction, financial impacts, or exhibits are disclosed in the filing summary. Sector not specified.

09-01-2026

MetLife Inc. filed a Form 8-K on January 9, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). The filing has Accession Number 0001099219-26-000005 and a size of 3 MB. No details on the content of the disclosure or exhibits are provided.

09-01-2026

Insmed Inc filed a Form 8-K on January 9, 2026 (AccNo: 0001140361-26-000778, Size: 7 MB), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the content of the disclosures, events, transactions, or financial data are provided in the filing summary.

09-01-2026

uniQure N.V. filed a Form 8-K on January 9, 2026 (AccNo: 0001104659-26-002317), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No details on core events, transactions, financial impacts, or numerical values are explicitly stated in the provided filing summary. This appears to be a multi-item voluntary disclosure related to Regulation FD compliance.

09-01-2026

BIOCRYST PHARMACEUTICALS INC filed a Form 8-K on January 09, 2026 (AccNo: 0001171843-26-000154, Size: 185 KB) under Item 7.01 Regulation FD Disclosure. This is a general filing with sector not specified. No further details on the disclosure content, events, transactions, or financial data are provided in the filing summary.

09-01-2026

MapLight Therapeutics, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-008267, size 16 MB) disclosing financial results under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results in the US market. No specific quantitative financial metrics, transaction values, or detailed outcomes are mentioned in the provided filing summary; sector not specified.

09-01-2026

Immunocore Holdings plc filed a Form 8-K on January 9, 2026 (AccNo: 0001140361-26-000780, size 9 MB), reporting Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results. No specific financial metrics, transaction values, or other numerical data disclosed in the provided filing summary.

09-01-2026

Aquestive Therapeutics, Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001398733-26-000003, Size: 1 MB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the event, transaction, financial statements, or exhibits are provided in the filing summary. Sector is not specified.

09-01-2026

Perspective Therapeutics, Inc. filed an 8-K on January 9, 2026 (AccNo: 0001193125-26-008277, Size: 274 KB) reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. Sector is not specified.

09-01-2026

Pegasystems Inc filed a Form 8-K on January 9, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No details on the specific event, transaction, financial impacts, or attached exhibits are disclosed in the provided filing summary. All quantitative metrics and core event descriptions are NOT_DISCLOSED.

09-01-2026

La Rosa Holdings Corp. filed a Form 8-K on January 9, 2026 (AccNo: 0001213900-26-002685, Size: 3 MB), reporting multiple material events including Entry into a Material Definitive Agreement (Item 1.01), Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement (Item 2.03), Unregistered Sales of Equity Securities (Item 3.02), Material Modifications to Rights of Security Holders (Item 3.03), and Amendments to Articles of Incorporation or Bylaws (Item 5.03), with Financial Statements and Exhibits under Item 9.01. This is a multi-item mandatory filing with no specific transaction details, dollar values, or quantitative impacts disclosed in the provided summary. Sector is not specified.

09-01-2026

Iovance Biotherapeutics, Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001104659-26-002323, Size: 8 MB), reporting Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific event, transaction, financial impacts, or other quantitative data are disclosed in the provided filing summary. Sector not specified.

09-01-2026

Prelude Therapeutics Inc filed a Form 8-K on January 09, 2026 (AccNo: 0001193125-26-008280, Size: 14 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event details, transaction values, financial metrics, or other specifics are disclosed in the provided filing summary. Sector is not specified.

09-01-2026

Hillenbrand, Inc. filed an 8-K on January 9, 2026, under Item 7.01 for Regulation FD Disclosure. Accession number: 0001104659-26-002324; file size: 205 KB. No specific details on the disclosure content, events, transactions, or financial metrics are provided in the filing summary.

09-01-2026

NewAmsterdam Pharma Co N.V. filed an 8-K on January 9, 2026 (AccNo: 0001193125-26-008300, Size: 269 KB), reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a financial results disclosure for a company in an unspecified sector. No specific financial metrics, transaction values, or other quantitative details are provided in the filing summary.

09-01-2026

Intellia Therapeutics, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-008307, Size: 5 MB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on events, transactions, financial impacts, or quantitative data are explicitly stated in the provided filing summary. This is a multi-item voluntary or mandatory disclosure depending on the underlying events, but core event details are NOT_DISCLOSED.

09-01-2026

Savara Inc filed a Form 8-K on January 09, 2026 (AccNo: 0001193125-26-008301, size: 6 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event, transaction details, financial metrics, or other specifics are disclosed in the provided filing summary. This is a general filing from the US SEC with sector not specified.

09-01-2026

Compass, Inc. filed an 8-K on 2026-01-09 (AccNo: 0001563190-26-000019, Size: 1 MB) disclosing a merger/acquisition event via Items 1.01 (Entry into Material Definitive Agreement), 2.01 (Completion of Acquisition or Disposition of Assets), 2.03 (Creation of Direct Financial Obligation), 3.02 (Unregistered Sales of Equity Securities), 5.02 (Changes in Directors/Officers), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific parties, deal structure, valuation, consideration type, synergies, regulatory details, shareholder impacts, or quantitative financial metrics are disclosed in the provided filing summary. Sector not specified.

09-01-2026

Koppers Holdings Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001315257-26-000004, Size: 342 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements). The filing also includes Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer, position, reason, or quantitative data provided in the summary; sector not specified.

09-01-2026

Cartesian Therapeutics, Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001453687-26-000051, Size: 7 MB) reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the core event, transaction values, financial metrics, or other specifics are provided in the filing summary. All quantitative financial data is NOT_DISCLOSED.

09-01-2026

AXT INC filed a Form 8-K on January 09, 2026 (AccNo: 0001213900-26-002690, Size: 215 KB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results from US market. No specific financial metrics, transaction details, or numerical data are provided in the filing summary.

09-01-2026

Aptevo Therapeutics Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-008318, size: 700 KB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, equity sales, events, or quantitative data provided in the summary. Sector not specified.

09-01-2026

Atossa Therapeutics, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-008314, Size: 8 MB), disclosing financial results under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing focused on financial results. No specific quantitative financial metrics, transaction values, or other numerical data are mentioned.

09-01-2026

Rigetti Computing, Inc. filed a General Filing (likely Form 8-K) on January 09, 2026 (AccNo: 0001104659-26-002328, Size: 251 KB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on events, transactions, financials, or named entities are disclosed in the provided filing summary. Sector is not specified.

09-01-2026

Ondas Holdings Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001213900-26-002694, Size: 200 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the content of the disclosure, events, transactions, financial statements, or exhibits are provided in the filing summary. Sector is not specified.

09-01-2026

Evolus, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001570562-26-000003, Size: 201 KB), reporting under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. This constitutes a multi-item voluntary disclosure of financial results. No specific revenue, earnings, transaction values, or other quantitative financial metrics are disclosed in the provided filing summary.

09-01-2026

Anywhere Real Estate Inc. filed an 8-K on 2026-01-09 (AccNo: 0001193125-26-008327, Size: 290 KB) announcing completion of an acquisition or disposition of assets (Item 2.01), notice of delisting or failure to satisfy listing standards (Item 3.01), material modifications to rights of security holders (Item 3.03), changes in control of the registrant (Item 5.01), changes in directors/officers (Item 5.02), and amendments to articles of incorporation or bylaws (Item 5.03). Item 9.01 includes financial statements and exhibits. No specific details on parties, deal structure, valuation, or financial metrics are disclosed.

09-01-2026

GRI Bio, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001824293-26-000006, size: 206 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other event, transaction, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.

09-01-2026

CG Oncology, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-008329, Size: 15 MB) as a General Filing from us_sec, reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on events, transactions, financials, or quantitative data provided in the summary. Sector is not specified.

09-01-2026

PDS Biotechnology Corp filed a Form 8-K on January 09, 2026 (AccNo: 0001140361-26-000786, Size: 178 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the core event, transaction values, financial impacts, or other quantitative data are disclosed in the provided filing summary. Sector is not specified.

09-01-2026

Onfolio Holdings, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001654954-26-000212, Size: 165 KB) disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, including transfer of listing. No specific reasons, financial details, transaction values, or quantitative impacts are provided in the available information. Sector is not specified.

09-01-2026

Willis Lease Finance Corp filed a Form 8-K on January 9, 2026, reporting under Item 8.01 Other Events. Accession number 0001018164-26-000007, file size 142 KB. No details on the specific event, transaction, financial impacts, or quantitative data disclosed in the provided filing summary.

09-01-2026

Marriott International Inc /MD/ filed a Form 8-K on January 09, 2026 (AccNo: 0001193125-26-008335, size 163 KB), disclosing an officer change, departure, election, or compensatory arrangements under Item 5.02, Regulation FD disclosure under Item 7.01, and financial statements/exhibits under Item 9.01. Event type is Officer Change from US SEC source. No specific details on affected officers, positions, reasons, or quantitative impacts provided.

09-01-2026

Rhythm Pharmaceuticals, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001628280-26-001459, Size: 11 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing focused on financial results and related disclosures. No specific financial metrics, transaction values, revenue, earnings, or other quantitative details are disclosed in the provided filing summary.

09-01-2026

Pulse Biosciences, Inc. disclosed an officer change via Form 8-K filed on January 9, 2026 (AccNo: 0001437749-26-000938, Size: 177 KB), under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer involved, position affected, appointment/resignation status, reasons, or any quantitative data provided in the filing summary. Sector not specified.

09-01-2026

Autonomix Medical, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001437749-26-000937, Size: 2 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the core event, transaction, financial impacts, or quantitative data are disclosed in the provided filing summary. This appears to be a multi-item voluntary disclosure under Regulation FD.

09-01-2026

FIRST COMMUNITY CORP /SC/ filed an 8-K on January 09, 2026 (AccNo: 0001552781-26-000009), announcing under Item 2.01 the completion of an acquisition or disposition of assets. The filing also covers Item 5.02 (changes in directors or officers, including compensatory arrangements), Item 8.01 (other events), and Item 9.01 (financial statements and exhibits). No specific details on deal parties, structure, valuation, or financial metrics are disclosed in the provided summary.

09-01-2026

Ellington Credit Co filed a Form 8-K on January 09, 2026 (AccNo: 0001628280-26-001461, Size: 147 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other event, transaction, financial statements, or exhibits are disclosed in the provided filing summary. This is a multi-item voluntary disclosure with all core event details NOT_DISCLOSED.

09-01-2026

Aclarion, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001683168-26-000168, size 682 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. This is a multi-item mandatory disclosure of a core material event involving an unspecified agreement. No transaction details, financial metrics, or dollar values are disclosed.

09-01-2026

OFS Capital Corp filed a Form 8-K on January 9, 2026 (AccNo: 0001487918-26-000006, size 243 KB), reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the agreement's nature, parties, terms, value, or financial impacts are provided in the filing summary. Sector is not specified.

09-01-2026

Vistra Corp. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-008508, Size: 147 KB) under Item 7.01 for Regulation FD Disclosure. No specific details on events, transactions, financial impacts, or other quantitative data are disclosed in the provided filing summary. Sector is not specified.

09-01-2026

Hurco Companies Inc filed an 8-K on January 9, 2026 (AccNo: 0001104659-26-002361, 403 KB), reporting Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a standard financial results disclosure with no specific revenue, earnings, or transaction details provided in the summary. Sector not specified.

09-01-2026

Origin Bancorp, Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001516912-26-000004, Size: 222 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This appears to be a voluntary disclosure of material information, potentially including attached financial statements or exhibits. No core event details, transaction values, financial metrics, or other quantitative data are disclosed in the provided filing summary.

09-01-2026

MAGELLAN COPPER & GOLD Corp filed a Form 8-K on January 9, 2026 (AccNo: 0001683168-26-000181, size: 203 KB), reporting changes in its certifying accountant under Item 4.01 and financial statements and exhibits under Item 9.01. No details on the nature of the accountant change, disagreements, or financial exhibits are disclosed in the provided summary. This is a multi-item mandatory filing triggered by a material event.

09-01-2026

Heron Therapeutics, Inc. (/DE/) filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-008631, size: 238 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary disclosure under Regulation FD, with no specific details on the core event, transaction, or financial impacts provided in the filing summary. Sector not specified.

09-01-2026

HILLS BANCORPORATION filed a Form 8-K on January 9, 2026 (AccNo: 0000732417-26-000003), reporting under Item 4.01 a change in its certifying accountant. No details on the former or new auditor, reasons for change, financial impacts, or other quantitative data are disclosed in the provided filing summary. This is a single-item mandatory disclosure for a material event.

09-01-2026

Kopin Corp filed a Form 8-K on January 9, 2026 (AccNo: 0001493152-26-001064, size 199 KB), disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, positions, reasons, or terms are provided. Sector not specified.

09-01-2026

Venu Holding Corp filed a Form 8-K on January 09, 2026 (AccNo: 0001493152-26-001075, Size: 2 MB), reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), amendments to articles of incorporation or bylaws or change in fiscal year (Item 5.03), and financial statements and exhibits (Item 9.01). This is a multi-item mandatory filing with no specific transaction details, dollar values, parties, or financial metrics disclosed in the provided summary. Sector not specified.

09-01-2026

ECB Bancorp, Inc. /MD/ filed a Form 8-K on January 09, 2026 (AccNo: 0001437749-26-000982, Size: 168 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the event, transaction, financial statements, or exhibits are provided in the filing summary. Sector not specified.

09-01-2026

Proficient Auto Logistics, Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001213900-26-002912, Size: 215 KB), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the core event, transaction, financials, or exhibits are disclosed in the provided filing summary. Sector not specified.

09-01-2026

Ribbon Acquisition Corp. filed an 8-K on January 9, 2026 (AccNo: 0001213900-26-002915, Size: 256 KB), disclosing Item 5.07 regarding Submission of Matters to a Vote of Security Holders, likely related to a merger/acquisition vote. Item 9.01 covers Financial Statements and Exhibits. No specific details on deal structure, parties, valuation, vote outcomes, or financial metrics are provided in the filing summary.

09-01-2026

Polaris Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001628280-26-001582, size 137 KB), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or any quantitative data are provided in the summary. Sector not specified.

09-01-2026

Advantage Solutions Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-008903, Size: 254 KB), reporting Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No additional details on delisting reasons, financial impacts, transaction values, or sector are disclosed. This indicates a delisting event from the US market.

09-01-2026

MSP Recovery, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-008897, size 1 MB), reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 2.04 triggering events accelerating or increasing such obligations, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific transaction details, dollar values, or financial metrics disclosed in the provided information. Sector not specified.

09-01-2026

PENN Entertainment, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001140361-26-000833, Size: 245 KB), reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer position, appointment/resignation status, reasons, or quantitative data are disclosed in the provided summary.

09-01-2026

Athira Pharma, Inc. filed an 8-K on 2026-01-09 (AccNo: 0001193125-26-008904) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer position, appointment/resignation status, reasons, or named individuals are disclosed. No quantitative data such as transaction values, share counts, or financial metrics are mentioned.

09-01-2026

LiveWire Group, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001898795-26-000008, Size: 174 KB) disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details such as the key position affected, individual names, appointment or resignation status, reasons, or any quantitative data are NOT_DISCLOSED in the provided information. Sector is not specified.

09-01-2026

Terns Pharmaceuticals, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-008907, Size: 187 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a financial results announcement with no specific revenue, earnings, balance sheet details, or quantitative metrics disclosed in the provided summary. Filing appears to be a standard voluntary or mandatory earnings-related disclosure.

09-01-2026

JOINT Corp filed a Form 8-K on January 9, 2026 (AccNo: 0001612630-26-000004, Size: 166 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement. Item 9.01 includes Financial Statements and Exhibits. No details on the agreement, transaction value, parties, or financial impacts are disclosed.

09-01-2026

Chart Industries Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-008906, Size: 136 KB), disclosing an officer change under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details such as the affected officer's name, title (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, or any quantitative data like compensation amounts are provided in the available information. Sector is not specified.

09-01-2026

BANK OF THE JAMES FINANCIAL GROUP INC filed a Form 8-K on January 09, 2026 (AccNo: 0001275101-26-000002, Size: 193 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the officer, position, reason, or quantitative data provided in the filing summary.

09-01-2026

ProFrac Holding Corp. filed a Form 8-K on January 9, 2026 (AccNo: 0001104659-26-002446, Size: 306 KB), reporting under Item 1.01 entry into a material definitive agreement and Item 2.03 creation of a direct financial obligation or obligation under an off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, parties, or quantitative metrics are provided in the filing summary.

09-01-2026

System1, Inc. disclosed an officer change event via Form 8-K filed on 2026-01-09 (AccNo: 0001805833-26-000003, Size: 145 KB) under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or compensation are provided in the available information. Sector is not specified.

09-01-2026

ConnectM Technology Solutions, Inc. filed an 8-K on 2026-01-09 (AccNo: 0001104659-26-002451, Size: 518 KB) disclosing entry into a material definitive agreement (Item 1.01), completion of an acquisition or disposition of assets (Item 2.01), and unregistered sales of equity securities (Item 3.02). Item 9.01 includes financial statements and exhibits. No details on parties, deal structure, valuation, consideration, or strategic rationale are disclosed.

09-01-2026

BITMINE IMMERSION TECHNOLOGIES, INC. filed a Form 8-K on 2026-01-09 (AccNo: 0001493152-26-001088, Size: 406 KB) disclosing an Officer Change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or any quantitative data are disclosed in the provided filing summary. Sector is not specified.

09-01-2026

Charles River Laboratories International, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001628280-26-001603, Size: 142 KB) disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected position, individual involved, nature of change (appointment or resignation), reasons, or compensation are provided. Sector not specified.

09-01-2026

Keros Therapeutics, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001664710-26-000003, Size: 4 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No core event details, financial metrics, transaction values, or other quantitative data are explicitly stated in the provided filing summary. This is a multi-item voluntary disclosure under Regulation FD.

09-01-2026

Thryv Holdings, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001140361-26-000830, Size: 322 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the officer position, appointment/resignation, reasons, or quantitative data are provided.

09-01-2026

Black Spade Acquisition III Co filed an 8-K on 2026-01-09 (AccNo: 0001104659-26-002447, size: 2 MB) announcing a merger/acquisition event with Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on deal structure, parties, valuation, or quantitative metrics are disclosed in the provided filing summary. Sector is not specified.

09-01-2026

Eureka Acquisition Corp filed an 8-K on January 09, 2026 (AccNo: 0001213900-26-002903, Size: 318 KB), disclosing entry into a Material Definitive Agreement under Item 1.01, creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, unregistered sales of equity securities under Item 3.02, and financial statements/exhibits under Item 9.01. This filing relates to a Merger/Acquisition event in the US market. No specific details on parties, deal structure, valuation, consideration, synergies, or financial metrics are disclosed.

09-01-2026

CF Industries Holdings, Inc. filed a Form 8-K on January 09, 2026, under Item 8.01 Other Events. Accession Number: 0001104659-26-002476. File size: 187 KB; no specific event details, transaction values, or financial metrics disclosed.

09-01-2026

Vishay Intertechnology Inc filed a Form 8-K on January 9, 2026 (AccNo: 0000103730-26-000003, size 168 KB), reporting changes in its certifying accountant under Item 4.01. Item 9.01 discloses financial statements and exhibits. No additional details on the change, reasons, new accountant, or exhibits are provided.

09-01-2026

Tempest Therapeutics, Inc. filed a Form 8-K on 2026-01-09 (AccNo: 0001193125-26-008938, Size: 174 KB) reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. This indicates a delisting event from the US market effective around January 09, 2026. No additional details on reasons, financial impacts, transaction values, or other metrics are disclosed.

09-01-2026

zSpace, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001104659-26-002478, Size: 219 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No details on the nature of the agreement, transaction value, counterparties, or exhibits are disclosed in the provided summary. Sector is not specified.

09-01-2026

Quanex Building Products CORP filed a Form 8-K on January 9, 2026, reporting under Item 8.01 Other Events. The filing has Accession Number 0001104659-26-002477 and a file size of 186 KB. No specific details on the event, transaction values, financial impacts, or other quantitative data are disclosed in the provided filing summary.

09-01-2026

Inflection Point Acquisition Corp. V filed an 8-K on January 9, 2026 (AccNo: 0001213900-26-002931, Size: 280 KB) disclosing entry into a Material Definitive Agreement (Item 1.01), creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement (Item 2.03), and Financial Statements and Exhibits (Item 9.01). This pertains to a Merger/Acquisition event in an unspecified sector. No specific details on parties, structure, valuation, or terms are disclosed in the provided filing summary.

09-01-2026

Community Healthcare Trust Inc filed a Form 8-K on January 9, 2026 (AccNo: 0001104659-26-002475, Size: 200 KB) disclosing an officer change under Item 5.02, covering departures of directors or certain officers, elections or appointments of directors or officers, or compensatory arrangements. Item 9.01 references financial statements and exhibits. No specific details on the officer involved, position, nature of change (appointment or resignation), reasons, or quantitative data are provided.

09-01-2026

RadNet, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001683168-26-000190, Size: 217 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). Specific details including the key position affected, officer name, appointment or resignation status, reasons, and any quantitative data are NOT_DISCLOSED.

09-01-2026

ACTELIS NETWORKS INC filed a Form 8-K on January 09, 2026 (AccNo: 0001213900-26-002925, Size: 219 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item general filing from the US SEC with no further details on the events or exhibits provided. Sector not specified; all transaction, financial, and event specifics are NOT_DISCLOSED.

09-01-2026

CEMTREX INC filed a Form 8-K on January 9, 2026 (AccNo: 0001493152-26-001101, Size: 691 KB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, events, transaction value, or financial impacts are disclosed in the provided summary. Sector is not specified.

09-01-2026

High Roller Technologies, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001753926-26-000084, Size: 390 KB), reporting multiple items including entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), departure/election of directors or officers and compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). This is a multi-item mandatory filing classified as a Material Event, but specific transaction details, values, or parties are NOT_DISCLOSED. Sector is not specified.

09-01-2026

LGL GROUP INC disclosed an Item 5.02 event on Form 8-K filed January 9, 2026 (AccNo: 0001437749-26-000991, Size: 181 KB), regarding Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the officer involved, position, appointment/resignation status, or reasons provided in the summary. Sector not specified.

09-01-2026

SoFi Technologies, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001818874-26-000005, Size: 136 KB), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position, appointment/resignation status, reasons, or compensation are provided in the filing summary. Sector is not specified.

09-01-2026

Portsmouth Square Inc filed a Form 8-K on January 9, 2026 (AccNo: 0001493152-26-001107, Size: 201 KB) disclosing an officer change under Item 5.02. Item 5.02 covers Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details including key position affected, appointment/resignation status, reasons, or individuals involved are NOT_DISCLOSED.

09-01-2026

LM Funding America, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-008955, Size: 159 KB), reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No specific details on the delisting reason, dollar values, financial impacts, share counts, or sector are disclosed. This appears to be a single-item mandatory disclosure event.

09-01-2026

Microvast Holdings, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0000947871-26-000019, Size: 276 KB) disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 lists financial statements and exhibits. No specific details on the officer involved, position affected, nature of change (appointment/resignation), reasons, or any quantitative data are provided in the filing summary.

09-01-2026

Fat Brands, Inc. filed an 8-K on 2026-01-09 (AccNo: 0001493152-26-001117) reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Event dated January 09, 2026. No sector specified and no additional details such as transaction values or financial impacts disclosed.

09-01-2026

Trio Petroleum Corp filed a Form 8-K on January 09, 2026 (AccNo: 0001493152-26-001116, Size: 676 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. Sector is not specified. No specific details on the agreement, transaction value, financial impacts, or other quantitative data are disclosed.

09-01-2026

Camp4 Therapeutics Corp filed a Form 8-K on January 09, 2026 (AccNo: 0001736730-26-000004, Size: 3 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item general filing with no specific core event, transaction details, financial metrics, or quantitative data disclosed in the provided information. Sector not specified.

09-01-2026

KKR Real Estate Finance Trust Inc. disclosed an officer change via Form 8-K filed on January 9, 2026 (AccNo: 0001140361-26-000843, Size: 199 KB) under Item 5.02, covering Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position, reason for change, or any quantitative data are provided in the available information. Sector is not specified.

09-01-2026

TENAX THERAPEUTICS, INC. filed a Form 8-K on January 9, 2026 (AccNo: 0001654954-26-000232, Size: 162 KB) disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the officer involved, position, reason, or compensation are provided in the filing summary.

09-01-2026

PEDEVCO CORP filed a Form 8-K on January 09, 2026 (AccNo: 0001654954-26-000231, Size: 151 KB), reporting under Item 2.03 the creation of a direct financial obligation or off-balance sheet arrangement, and under Item 5.07 the submission of matters to a vote of security holders. No specific details on the nature, size, or terms of the financial obligation or the shareholder vote matters are disclosed in the provided filing summary. Sector is not specified.

09-01-2026

Willis Towers Watson PLC filed an 8-K on January 9, 2026 (AccNo: 0001193125-26-009009, Size: 950 KB) reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, with Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. This is a multi-item mandatory filing indicating material events.

09-01-2026

Oracle Corp filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-009002, Size: 130 KB) disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position, appointment or resignation status, reasons, or other impacts are provided in the available information. Sector is not specified.

09-01-2026

Monte Rosa Therapeutics, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-009005, size 677 KB), reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No details on the core event, transaction value, parties involved, financial impacts, or strategic importance are disclosed in the provided information. This is a multi-item filing with no quantitative data available.

09-01-2026

XMax Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001493152-26-001109, Size: 243 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on positions, individuals, reasons, or quantitative data provided.

09-01-2026

KKR & Co. Inc. disclosed an officer change via Form 8-K filed on January 9, 2026 (AccNo: 0001140361-26-000841, Size: 214 KB), under Item 5.02 covering departures, elections, appointments of directors/officers, or compensatory arrangements. Specific details on the officer involved, position, appointment/resignation status, reasons, or impacts are NOT_DISCLOSED. Sector is not specified.

09-01-2026

Aprea Therapeutics, Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001104659-26-002490, Size: 4 MB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, or exhibits are disclosed in the provided filing summary. Sector is not specified.

09-01-2026

BRAINSTORM CELL THERAPEUTICS INC. filed a Form 8-K on January 9, 2026 (AccNo: 0001104659-26-002494, Size: 1 MB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure with no specific details on the agreement, transaction values, share counts, or other quantitative data provided in the summary. Sector is not specified.

09-01-2026

Boot Barn Holdings, Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001104659-26-002514, Size: 4 MB), disclosing under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing reports financial results. No specific revenue, earnings, transaction values, or other quantitative metrics are mentioned.

09-01-2026

TruGolf Holdings, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001493152-26-001110, Size: 200 KB) reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No specific details on the core event, reasons for delisting, financial impacts, transaction values, or other quantitative data are disclosed. Sector is not specified.

09-01-2026

Greenbrier Companies Inc filed an 8-K on January 9, 2026 (AccNo: 0001193125-26-008997, Size: 159 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 5.07 (Submission of Matters to a Vote of Security Holders). No specific details such as affected position, appointment/resignation status, reasons, names, or quantitative data are provided in the filing summary. This is a routine governance disclosure with limited visibility into implications.

09-01-2026

Aptera Motors Corp filed a Form 8-K on January 09, 2026 (AccNo: 0001493152-26-001121, Size: 16 MB), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the core event, transaction, financials, or other specifics are provided in the filing summary.

09-01-2026

Steven Madden, Ltd. filed a Form 8-K on January 9, 2026 (AccNo: 0001493152-26-001108), disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. Item 9.01 indicates financial statements and exhibits are included. No specific details on the officer, position, reason, or terms are provided in the filing summary.

09-01-2026

LendingTree, Inc. disclosed an officer change via Form 8-K filed on 2026-01-09 (AccNo: 0001683168-26-000191, Size: 211 KB). The filing covers Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer, position, nature of change, or reasons provided.

09-01-2026

Lakeland Industries Inc. filed a Form 8-K on 2026-01-09 (AccNo: 0001193125-26-008983, Size: 144 KB) disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected officer, position, reason for change, or any quantitative data are provided in the filing summary. Sector is not specified.

09-01-2026

Ducommun Inc./DE/ filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-009036, Size: 144 KB) reporting under Item 7.01 Regulation FD Disclosure. No specific details on the core event, transaction, financial metrics, or other content are disclosed in the provided filing summary. This appears to be a voluntary disclosure with sector not specified.

09-01-2026

Webster Financial Corp filed an 8-K on January 9, 2026 (AccNo: 0000801337-26-000002, Size: 472 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation, reasons, or compensation are provided in the available information. Sector not specified.

09-01-2026

Ocean Power Technologies, Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001493152-26-001119, Size: 292 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event details, transaction values, financial metrics, or other specifics are disclosed in the provided filing summary. Sector is not specified.

09-01-2026

Soho House & Co Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001140361-26-000848, Size: 166 KB), reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details on the shareholder meeting matters, vote results, numerical data, or financial implications are explicitly stated in the provided filing information. This appears to be a single-item, mandatory disclosure.

09-01-2026

Genprex, Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001437749-26-000995, Size: 162 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No details on the specific other events, financial statements, or exhibits are disclosed in the provided filing summary. All transaction values, financial metrics, and quantitative impacts are NOT_DISCLOSED.

09-01-2026

BED BATH & BEYOND, INC. filed a Form 8-K on January 09, 2026 (AccNo: 0001140361-26-000846, Size: 195 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.

09-01-2026

Abacus Global Management, Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001628280-26-001644, Size: 1 MB), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event details, transaction values, financial metrics, or other quantitative data are disclosed. This appears to be a multi-item voluntary disclosure under Regulation FD.

09-01-2026

Brink's Co (BRINKS CO) filed an 8-K on January 9, 2026 (AccNo: 0000078890-26-000002, Size: 143 KB) under Item 5.02 disclosing a potential departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the officer involved, position, reason, or terms are provided in the available summary. Sector not specified.

09-01-2026

Vicarious Surgical Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001213900-26-002973, Size: 190 KB), reporting Item 5.07: Submission of Matters to a Vote of Security Holders. This is a single-item filing disclosing shareholder vote results. No specific vote outcomes, proposals, numbers, or other details are provided.

09-01-2026

NOVAGOLD RESOURCES INC filed a Form 8-K on January 9, 2026 (AccNo: 0001171843-26-000168, size 248 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event, transaction details, financial metrics, or other specifics are disclosed in the provided filing summary. This is a multi-item voluntary disclosure focused on Reg FD material information and attached exhibits.

09-01-2026

Southwest Gas Holdings, Inc. filed an 8-K on January 09, 2026 (AccNo: 0001692115-26-000004), disclosing Items 2.02 (Results of Operations and Financial Condition), 4.02 (Non-Reliance on Previously Issued Financial Statements or Related Audit Report), and 7.01 (Regulation FD Disclosure). No specific financial metrics, transaction values, or quantitative data are provided in the filing summary. This multi-item filing signals potential accounting issues alongside operational results.

09-01-2026

Western Union Co filed Form 8-K on 2026-01-09 (AccNo: 0001193125-26-009094) reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), along with Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific transaction details, dollar values, counterparties, or financial metrics disclosed. Filing size is 1 MB; sector not specified.

09-01-2026

SAFE & GREEN HOLDINGS CORP. filed a Form 8-K on January 9, 2026 (AccNo: 0001213900-26-002999, Size: 234 KB), reporting a change in its certifying accountant under Item 4.01 and attaching financial statements and exhibits under Item 9.01. No details on the former or new accountant, reasons for the change, financial impacts, or other specifics are disclosed in the provided filing summary. This is a multi-item mandatory disclosure event.

09-01-2026

Momentus Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001140361-26-000853, Size: 1 MB), reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). This is a multi-item filing with no specific details on the agreement, transaction size, or equity sales provided in the summary. Sector not specified.

09-01-2026

Sun Country Airlines Holdings, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-009087, Size: 137 KB), disclosing an officer change under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position, appointment/resignation status, reasons, or any quantitative data are provided in the filing summary. Sector is not specified.

09-01-2026

Caring Brands, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001493152-26-001128, Size: 206 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or compensation provided in the available information. Sector not specified.

09-01-2026

Enlightify Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001213900-26-002986, Size: 199 KB), reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details on the matters submitted, vote results, numerical outcomes, or related entities are disclosed in the provided filing summary. This appears to be a single-item mandatory disclosure with no additional quantitative or qualitative event details available.

09-01-2026

Southern California Gas Co filed a Form 8-K on January 9, 2026 (AccNo: 0000092108-26-000004, Size: 390 KB) under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or any quantitative data such as compensation amounts or share counts are provided in the summary. Sector is not specified.

09-01-2026

BioLife Solutions Inc (BIOLIFE SOLUTIONS INC) filed an 8-K on January 9, 2026 (AccNo: 0001628280-26-001649, Size: 135 KB), disclosing an officer change under Item 5.02. Item 5.02 covers Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on positions, individuals, reasons, or compensation provided; sector not specified.

09-01-2026

Capstone Holding Corp. filed an 8-K on January 9, 2026 (AccNo: 0001213900-26-003008, Size: 193 KB), reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No specific details on the reason for the notice, transaction values, financial impacts, or other quantitative data are disclosed in the provided filing summary. Sector is not specified.

09-01-2026

Xenetic Biosciences, Inc. filed a Form 8-K on January 9, 2026, reporting under Item 8.01 Other Events. Accession number: 0001683168-26-000196; file size: 188 KB. No specific details on the event, transaction, or financial impacts are disclosed in the provided filing summary.

09-01-2026

Zentalis Pharmaceuticals, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001725160-26-000003, Size: 6 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 8.01 (Other Events). This is a multi-item filing with no specific details on events, transactions, or financial impacts disclosed in the provided information. Sector is not specified.

09-01-2026

Bark, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001628280-26-001646, Size: 215 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the event, transaction, financial statements, or exhibits are disclosed in the provided filing summary. Sector not specified.

09-01-2026

AnaptysBio, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001370053-26-000002, Size: 15 MB) reporting Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. This is a multi-item voluntary and mandatory disclosure filing typical for earnings releases.

09-01-2026

Janus International Group, Inc. disclosed an officer change via Form 8-K filed on January 9, 2026 (AccNo: 0001104659-26-002536, Size: 186 KB) under Item 5.02, covering departures, elections, appointments of directors or certain officers, and compensatory arrangements. No specific details on individuals, positions, reasons, or terms provided in the available information. Sector not specified.

09-01-2026

ProPhase Labs, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001493152-26-001143, Size: 238 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other event or the financial statements/exhibits are disclosed in the provided filing summary. Sector is not specified.

09-01-2026

FLYEXCLUSIVE INC. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-009100, Size: 986 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, events, or exhibits provided in the available information. Sector is not specified.

09-01-2026

XTI Aerospace, Inc. filed a Form 8-K on January 09, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). The filing also includes Item 3.02 (Unregistered Sales of Equity Securities) and Item 9.01 (Financial Statements and Exhibits). No specific details on positions, individuals, reasons, or numerical data are provided in the summary.

09-01-2026

Vistagen Therapeutics, Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001628280-26-001690, size: 7 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the specific content of the disclosure or exhibits are provided. Sector not specified.

09-01-2026

NKGen Biotech, Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001213900-26-003030, Size: 370 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, financial obligation, transaction value, parties involved, or impacts are disclosed in the provided summary. Sector is not specified.

09-01-2026

Glimpse Group, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001493152-26-001153, Size: 219 KB), reporting changes in its certifying accountant under Item 4.01 and financial statements and exhibits under Item 9.01. No specific details on the auditor change, financials, transaction values, or other metrics are disclosed in the provided filing summary. Sector is not specified.

09-01-2026

Enveric Biosciences, Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001493152-26-001151, Size: 9 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary disclosure with no core event, transaction details, or quantitative financial data explicitly stated in the provided filing summary. Sector is not specified.

09-01-2026

UPEXI, INC. filed a Form 8-K on January 09, 2026 (AccNo: 0001477932-26-000137, Size: 167 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the 'Other Events' or contents of the financial statements/exhibits are disclosed. Sector is not specified.

09-01-2026

Brag House Holdings, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001213900-26-003029, Size: 189 KB), reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No specific reasons for delisting, exchange involved, financial impacts, or transaction details are disclosed. Sector is not specified.